Dual-roadmap guidance for endovascular recanalization of medically refractory non-acute intracranial arterial occlusions: consecutive multicenter series and technical review

医学 耐火材料(行星科学) 外科 血管内治疗 放射科 动脉瘤 天体生物学 物理
作者
Feng Gao,Xu Guo,Xuan Sun,Yan Liu,Yingchun Wu,Zhongrong Miao
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:13 (10): 889-893 被引量:12
标识
DOI:10.1136/neurintsurg-2020-016754
摘要

Background The optimal treatment for medically refractory non-acute intracranial artery occlusion is uncertain, and endovascular recanalization remains a technical challenge. Here, a multicenter clinical experience of dual-roadmap guidance for endovascular recanalization of non-acute intracranial artery occlusion is reported, focusing on the technical feasibility and safety. Methods From January 2014 to December 2019, 52 consecutive patients with medically refractory atherosclerotic non-acute intracranial artery occlusion who underwent endovascular recanalization under dual-roadmap guidance in three large regional referral stroke centers were analyzed retrospectively. Four types of dual-roadmap technical schemes were applied during endovascular recanalization. The rates of technical success, periprocedural complications, any stroke or death within 30 days, and follow-up results were evaluated. Results The technical success rate was 92.3% (48/52). The perioperative complication rate was 7.7% (4/52), and the rate of any stroke or death within 30 days was 3.8% (2/52). Asymptomatic dissection occurred in two patients, acute in-stent thrombosis followed by postoperative mild stroke (National Institutes of Health Stroke Scale (NIHSS) 3) in one patient, and death due to reperfusion hemorrhage after successful recanalization in one patient. The rate of stroke or death beyond 30 days was 6.5% (3/46). The median clinical follow-up period was 19 months, and the median imaging follow-up period was 12 months. The restenosis rate was 13.2% (5/38). Conclusions Endovascular recanalization of non-acute intracranial occlusions can be performed with a high rate of technical success and few complications with assistance of the dual-roadmap technique for navigation. Four types of dual-roadmap schemes provide technical references.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Fll给Fll的求助进行了留言
4秒前
4秒前
小牛应助研友_LmbRgn采纳,获得10
4秒前
天天快乐应助xixili采纳,获得10
5秒前
yixi关注了科研通微信公众号
5秒前
烟花应助alexlpb采纳,获得10
6秒前
7秒前
OK完成签到,获得积分10
7秒前
10秒前
墨零发布了新的文献求助10
10秒前
芙芙应助搞怪的谷蕊采纳,获得10
12秒前
安详世平发布了新的文献求助10
12秒前
Zerone01001完成签到,获得积分10
12秒前
ACC完成签到 ,获得积分10
13秒前
13秒前
科研通AI6.1应助细腻听白采纳,获得10
15秒前
15秒前
16秒前
16秒前
bjut发布了新的文献求助10
17秒前
17秒前
大个应助白雪皑皑采纳,获得10
18秒前
森宇暖树发布了新的文献求助10
18秒前
念柏完成签到,获得积分10
18秒前
米奇奇奇关注了科研通微信公众号
19秒前
adad发布了新的文献求助10
20秒前
斯文凝蕊发布了新的文献求助10
20秒前
wang完成签到,获得积分20
20秒前
cc关闭了cc文献求助
21秒前
22秒前
alexlpb发布了新的文献求助10
22秒前
郑大王完成签到,获得积分20
22秒前
打不溜应助橙子采纳,获得10
26秒前
27秒前
星星应助DYH采纳,获得40
28秒前
28秒前
cici完成签到 ,获得积分10
28秒前
大模型应助森宇暖树采纳,获得10
29秒前
谓风发布了新的文献求助10
30秒前
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Graphene Handbook (2019 Edition) 800
Adhesion Science: Principles & Practice 800
Signals, Systems, and Signal Processing 610
IEST-RP-CC018: Cleanroom Cleaning and Sanitization: Operating and Monitoring Procedures 600
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 600
How to Design, Write and Publish Qualitative Research for Insight and Impact 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6534081
求助须知:如何正确求助?哪些是违规求助? 8327455
关于积分的说明 17837834
捐赠科研通 5635718
什么是DOI,文献DOI怎么找? 2934212
邀请新用户注册赠送积分活动 1910519
关于科研通互助平台的介绍 1769046